The New York Times – Business:
Trials of experimental gene therapy for sickle cell disease were halted when patients developed worrying illnesses.
Blog
-
For Creators, Everything Is for Sale
The New York Times – Business:
Digital stars are coming up with new ways to make money. Yet fans still hold the power.
-
Inflation remained mild in February, despite a jump in gasoline prices.
The New York Times – Business:
-
Lina Khan Would Bring a Tough Antitrust Voice
The New York Times – Business:
Lina Khan would bring another progressive voice to competition oversight.
-
Xi’s Gambit: China Plans for a World Without American Technology
The New York Times – Business:
Beijing’s leaders plot a path to go it alone, vowing to spend big to fill gaps in innovation and avoid dependence on the United States and others.
-
Deepfake Videos of Eerie Tom Cruise Revive Debate
The New York Times – Business:
A tool that allows old photographs to be animated, and viral videos of a Tom Cruise impersonation, shined new light on digital impersonations.
-
The Mayor’s House Was Firebombed. The Message: Keep Our Town Nuclear-Free.
The New York Times – Business:
A furor in an ailing Japanese fishing outpost shows the deep anxiety that remains in the country 10 years after the Fukushima disaster.
-
Black and Hispanic communities are confronted with vaccine misinformation.
The New York Times – Business:
-
A $22,368 Bill That Dodged and Weaved to Find a Gap in America’s Health System
The New York Times – Business:
Bad news for one unlucky patient is also a stark example of how dysfunctional U.S. health coverage can be.
